Press release from the International Trail Running Association (ITRA). ITRA’s athlete drug testing program is formally known as its Health Policy.
The procedure was to test the top 10 men and women from the ITRA (International Trail Running Association) general ranking and the best men and woman from each delegation.
On the 77 athletes selected from this procedure, 76 had been tested. 1 athlete could not be tested due to delay in its transportation and its late arrival Friday, October 28, 2016. After checking this information, the athlete was allowed to take the start by the ITRA medical commission.
Biological analysis carried out on blood samples involved a blood count with reticulocytes (total of 17 factors).
The overall results are shown in the table below:
Total number of profiles: 76
Including a number of profiles classified as “normal” by the ITRA health commission : 68
Including a number of profiles classified as “with a potential disease” by the ITRA health commission : 5
Including a number of profiles classified as “atypical” by the ITRA health commission : 3
Including a number of profiles classified as “abnormal” by the ITRA health commission : 0
No start for the race : 0
Each athlete can access his results from its free ITRA health space. Each athlete with a profile classified “with a potential disease” by the ITRA health commission is also notified by mail to come closer to his doctor. Some information about profiles can be exchanged with the organizations in charge of the fight against doping.
Patrick Basset, M.D.
President of the ITRA Health Commission
Pierre Sallet, Ph.D.
Manager of the ITRA Health Policy